InvestorsHub Logo

north40000

12/17/20 3:51 PM

#1498 RE: MinnieM #1497

The image you see is from a Bhatt et al paper in a recent European Heart Journal.
Amarin’s Vascepa is the subject, now in a host of phase IV clinical trials for varied indications. Kaiser-Permanente has a large one involving treatment of COVID-19 virus infection.